The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway
Open accessAbstract
Nucleotide-binding oligomerization domain 1 (NOD1) is an intracellular epithelial cell protein known to play a role in host defense at mucosal surfaces. Here we show that a ligand specific for NOD1, a peptide derived from peptidoglycan, initiates an unexpected signaling pathway in human epithelial cell lines that results in the production of type I IFN. Detailed analysis revealed the components of the signaling pathway. NOD1 binding to its ligand triggered activation of the serine-threonine kinase RICK, which was then able to bind TNF receptor-associated factor 3 (TRAF3). This in turn led to activation of TANK-binding kinase 1 (TBK1) and IkappaB kinase epsilon (IKKepsilon) and the subsequent activation of IFN regulatory factor 7 (IRF7). IRF7 induced IFN-beta production, which led to activation of a heterotrimeric transcription factor complex known as IFN-stimulated gene factor 3 (ISGF3) and the subsequent production of CXCL10 and additional type I IFN. In vivo studies showed that mice lacking the receptor for IFN-beta or subjected to gene silencing of the ISGF3 component Stat1 exhibited decreased CXCL10 responses and increased susceptibility to Helicobacter pylori infection, phenotypes observed in NOD1-deficient mice. These studies thus establish that NOD1 can activate the ISGF3 signaling pathway that is usually associated with protection against viral infection to provide mice with robust type I IFN-mediated protection from H. pylori and possibly other mucosal infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Helicobacter pylori Infection and the Development of Gastric Cancer
Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N., & Schlemper, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa001999 · Cited by 4,465
‘Green mice’ as a source of ubiquitous green cells
Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T., & Nishimune, Y. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00313-x · Cited by 2,581
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Chamaillard, M., Hashimoto, M., Horie, Y., Masumoto, J., Qiu, S., Saab, L., Ogura, Y., Kawasaki, A., Fukase, K., Kusumoto, S., et al. (2003) · Nature Immunology · doi:10.1038/ni945 · Cited by 1,323
Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island
Viala, J., Chaput, C., Boneca, I. G., Cardona, A., Girardin, S. E., Moran, A. P., Athman, R., Mémet, S., Huerre, M. R., Coyle, A. J., et al. (2004) · Nature Immunology · doi:10.1038/ni1131 · Cited by 1,226
NODs: intracellular proteins involved in inflammation and apoptosis
Inohara, N., & Nuñez, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1086 · Cited by 1,064
NOD-LRR PROTEINS: Role in Host-Microbial Interactions and Inflammatory Disease
Inohara, N., Chamaillard, M., McDonald, C., & Nuñez, G. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133347 · Cited by 991
Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6
Häcker, H., Redecke, V., Blagoev, B., Kratchmarova, I., Hsu, L.-C., Wang, G. G., Kamps, M. P., Raz, E., Wagner, H., Häcker, G., et al. (2006) · Nature · doi:10.1038/nature04369 · Cited by 968
RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems
Kobayashi, K., Inohara, N., Hernandez, L. D., Galán, J. E., Núñez, G., Janeway, C. A., Medzhitov, R., & Flavell, R. A. (2002) · Nature · doi:10.1038/416194a · Cited by 893
Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response
Oganesyan, G., Saha, S. K., Guo, B., He, J. Q., Shahangian, A., Zarnegar, B., Perry, A., & Cheng, G. (2006) · Nature · doi:10.1038/nature04374 · Cited by 881
Signalling pathways and molecular interactions of NOD1 and NOD2
Strober, W., Murray, P. J., Kitani, A., & Watanabe, T. (2006) · Nature Reviews Immunology · doi:10.1038/nri1747 · Cited by 856
Self-citationNOD2 is a negative regulator of Toll-like receptor 2–mediated T helper type 1 responses
Watanabe, T., Kitani, A., Murray, P. J., & Strober, W. (2004) · Nature Immunology · doi:10.1038/ni1092 · Cited by 840
Self-citationImpaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency
Dupuis, S., Jouanguy, E., Al-Hajjar, S., Fieschi, C., Al-Mohsen, I. Z., Al-Jumaah, S., Yang, K., Chapgier, A., Eidenschenk, C., Eid, P., et al. (2003) · Nature Genetics · doi:10.1038/ng1097 · Cited by 816
A Toll-like receptor–independent antiviral response induced by double-stranded B-form DNA
Ishii, K. J., Coban, C., Kato, H., Takahashi, K., Torii, Y., Takeshita, F., Ludwig, H., Sutter, G., Suzuki, K., Hemmi, H., et al. (2006) · Nature Immunology · doi:10.1038/ni1282 · Cited by 775
NOD-Like Receptors: Role in Innate Immunity and Inflammatory Disease
Chen, G., Shaw, M. H., Kim, Y.-G., & Nuñez, G. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092239 · Cited by 772
Evasion of Toll-like receptor 5 by flagellated bacteria
Andersen-Nissen, E., Smith, K. D., Strobe, K. L., Barrett, S. L. R., Cookson, B. T., Logan, S. M., & Aderem, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502040102 · Cited by 657
CARD4/Nod1 mediates NF‐κB and JNK activation by invasive Shigella flexneri
Girardin, S. E., Tournebize, R., Mavris, M., Page, A., Li, X., Stark, G. R., Bertin, J., DiStefano, P. S., Yaniv, M., Sansonetti, P. J., et al. (2001) · EMBO reports · doi:10.1093/embo-reports/kve155 · Cited by 609
An Induced Proximity Model for NF-κB Activation in the Nod1/RICK and RIP Signaling Pathways
Inohara, N., Koseki, T., Lin, J., del Peso, L., Lucas, P. C., Chen, F. F., Ogura, Y., & Núñez, G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003415200 · Cited by 540
Gautier, G., Humbert, M., Deauvieau, F., Scuiller, M., Hiscott, J., Bates, E. E. M., Trinchieri, G., Caux, C., & Garrone, P. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041964 · Cited by 537
A weak signal for strong responses: interferon-alpha/beta revisited
Taniguchi, T., & Takaoka, A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35073080 · Cited by 483
Taniguchi, T., & Takaoka, A. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(01)00305-3 · Cited by 482
D'Elios, M. M., Manghetti, M., De Carli, M., Costa, F., Baldari, C. T., Burroni, D., Telford, J. L., Romagnani, S., & Del Prete, G. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.2.962 · Cited by 481
Matsumoto, Y., Marusawa, H., Kinoshita, K., Endo, Y., Kou, T., Morisawa, T., Azuma, T., Okazaki, I.-M., Honjo, T., & Chiba, T. (2007) · Nature Medicine · doi:10.1038/nm1566 · Cited by 479
Self-citationThe Yin and Yang of type I interferon activity in bacterial infection
Decker, T., Müller, M., & Stockinger, S. (2005) · Nature Reviews Immunology · doi:10.1038/nri1684 · Cited by 468
Toll-like receptor 9–induced type I IFN protects mice from experimental colitis
Katakura, K., Lee, J., Rachmilewitz, D., Li, G., Eckmann, L., & Raz, E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22996 · Cited by 451
Expression of NOD2 in Paneth cells: a possible link to Crohn’s ileitis
Ogura, Y., Lala, S., Xin, W., Smith, E., Dowds, T. A., Chen, F. F., Zimmermann, E., Tretiakova, M., Cho, J. H., Hart, J., et al. (2003) · Gut · doi:10.1136/gut.52.11.1591 · Cited by 440
RIP2 Is a Novel NF-κB-activating and Cell Death-inducing Kinase
McCarthy, J. V., Ni, J., & Dixit, V. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.16968 · Cited by 436
Fritz, J. H., Le Bourhis, L., Sellge, G., Magalhaes, J. G., Fsihi, H., Kufer, T. A., Collins, C., Viala, J., Ferrero, R. L., Girardin, S. E., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.03.009 · Cited by 331
Watanabe, T., Asano, N., Murray, P. J., Ozato, K., Tailor, P., Fuss, I. J., Kitani, A., & Strober, W. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33145 · Cited by 326
Self-citationThe neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses
Amedei, A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27177 · Cited by 324
Marx, N., Mach, F., Sauty, A., Leung, J. H., Sarafi, M. N., Ransohoff, R. M., Libby, P., Plutzky, J., & Luster, A. D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6503 · Cited by 296
Kim, J. G., Lee, S. J., & Kagnoff, M. F. (2004) · Infection and Immunity · doi:10.1128/iai.72.3.1487-1495.2004 · Cited by 252
Yang, Y., Yin, C., Pandey, A., Abbott, D., Sassetti, C., & Kelliher, M. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703079200 · Cited by 227
Masumoto, J., Yang, K., Varambally, S., Hasegawa, M., Tomlins, S. A., Qiu, S., Fujimoto, Y., Kawasaki, A., Foster, S. J., Horie, Y., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051229 · Cited by 212
Park, J.-H., Kim, Y.-G., Shaw, M., Kanneganti, T.-D., Fujimoto, Y., Fukase, K., Inohara, N., & Núñez, G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.514 · Cited by 192
Majumder, S., Zhou, L. Z.-H., Chaturvedi, P., Babcock, G., Aras, S., & Ransohoff, R. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4736 · Cited by 184
Control of canonical NF-κB activation through the NIK–IKK complex pathway
Zarnegar, B., Yamazaki, S., He, J. Q., & Cheng, G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707959105 · Cited by 183
Silencing T-bet Defines a Critical Role in the Differentiation of Autoreactive T Lymphocytes
Lovett-Racke, A. E., Rocchini, A. E., Choy, J., Northrop, S. C., Hussain, R. Z., Ratts, R. B., Sikder, D., & Racke, M. K. (2004) · Immunity · doi:10.1016/j.immuni.2004.09.010 · Cited by 183
Nod1-Mediated Endothelial Cell Activation by Chlamydophila pneumoniae
Opitz, B., Förster, S., Hocke, A. C., Maass, M., Schmeck, B., Hippenstiel, S., Suttorp, N., & Krüll, M. (2005) · Circulation Research · doi:10.1161/01.res.0000155721.83594.2c · Cited by 183
Fichtner-Feigl, S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24792 · Cited by 172
Self-citationMajumder, S., Zhou, L., Chaturvedi, P., Babcock, G., Aras, S., & Ransohoff, R. M. (1998) · PubMed · Cited by 171
Thomas, K. E., Galligan, C. L., Newman, R. D., Fish, E. N., & Vogel, S. N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604958200 · Cited by 170
Nod1 Participates in the Innate Immune Response to Pseudomonas aeruginosa
Travassos, L. H., Carneiro, L. A. M., Girardin, S. E., Boneca, I. G., Lemos, R., Bozza, M. T., Domingues, R. C. P., Coyle, A. J., Bertin, J., Philpott, D. J., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501649200 · Cited by 166
SGT1 is essential for Nod1 activation
Correia, J. D. S., Miranda, Y., Leonard, N., & Ulevitch, R. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610926104 · Cited by 146
GEF-H1 Mediated Control of NOD1 Dependent NF-κB Activation by Shigella Effectors
Fukazawa, A., Alonso, C., Kurachi, K., Gupta, S., Lesser, C. F., McCormick, B. A., & Reinecker, H. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000228 · Cited by 123
Regulation of Nod1-mediated signaling pathways
Correia, J. D. S., Miranda, Y., Leonard, N., Hsu, J. C., & Ulevitch, R. J. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402070 · Cited by 118
Veckman, V., Österlund, P., Fagerlund, R., Melén, K., Matikainen, S., & Julkunen, I. (2005) · Virology · doi:10.1016/j.virol.2005.09.043 · Cited by 111
Hisamatsu, T., Suzuki, M., & Podolsky, D. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304355200 · Cited by 100
Innate immune recognition of the extracellular mucosal pathogen, Helicobacter pylori
Ferrero, R. L. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2004.12.001 · Cited by 99
Yamamoto, M., Fujihashi, K., Kawabata, K., McGhee, J. R., & Kiyono, H. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.5.2188 · Cited by 85
Inhibition of RIP2/RICK/CARDIAK activity by pyridinyl imidazole inhibitors of p38 MAPK
Argast, G. M., Fausto, N., & Campbell, J. S. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-3701-0 · Cited by 75
Saito, N., Courtois, G., Chiba, A., Yamamoto, N., Nitta, T., Hironaka, N., Rowe, M., Yamamoto, N., & Yamaoka, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302549200 · Cited by 75
NOD2 regulation of Toll-like receptor responses and the pathogenesis of Crohn’s disease
Watanabe, T., Kitani, A., & Strober, W. (2005) · Gut · doi:10.1136/gut.2005.071795 · Cited by 74
Self-citationFujihashi, K., Kawabata, S., Hiroi, T., Yamamoto, M., McGhee, J. R., Nishikawa, S.-I., & Kiyono, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3613 · Cited by 71
IP-10 and Type 1 Diabetes: A Question of Time and Location
Christen, U., & von Herrath, M. G. (2004) · Autoimmunity · doi:10.1080/08916930410001713124 · Cited by 70
Hirata, Y., Ohmae, T., Shibata, W., Maeda, S., Ogura, K., Yoshida, H., Kawabe, T., & Omata, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3796 · Cited by 69
Yoshida, M., Shirai, Y., Watanabe, T., Yamori, M., Iwakura, Y., Chiba, T., Kita, T., & Wakatsuki, Y. (2002) · Gastroenterology · doi:10.1053/gast.2002.37049 · Cited by 26
Self-citationShin‐Ya, M., Hirai, H., Satoh, E., Kishida, T., Asada, H., Aoki, F., Tsukamoto, M., Imanishi, J., & Mazda, O. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.088 · Cited by 23
Cited by
Type I interferons in infectious disease
McNab, F., Mayer-Barber, K., Sher, A., Wack, A., & O'Garra, A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3787 · Cited by 2,780
Helicobacter pylori and Gastric Cancer: Factors That Modulate Disease Risk
Wroblewski, L. E., Peek, R. M., & Wilson, K. T. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00011-10 · Cited by 1,442
Helicobacter pylori: gastric cancer and beyond
Polk, D. B., & Peek, R. M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2857 · Cited by 1,158
NOD1 and NOD2: Signaling, Host Defense, and Inflammatory Disease
Caruso, R., Warner, N., Inohara, N., & Núñez, G. (2014) · Immunity · doi:10.1016/j.immuni.2014.12.010 · Cited by 830
Type I interferon: friend or foe?
Trinchieri, G. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20101664 · Cited by 844
Metadata
- Authors
- Watanabe, T., Asano, N., Fichtner-Feigl, S., Gorelick, P. L., Tsuji, Y., Matsumoto, Y., Chiba, T., Fuss, I. J., Kitani, A., & Strober, W.
- Venue
- Journal of Clinical Investigation
- Published
- 2010-05-03
- Volume
- 120
- Issue
- 5
- Pages
- 1645-1662
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2122364835
- Cited by
- 262
- References
- 58
- FWCI
- 9.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.